secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMV Pharmaceuticals, Inc. (PMVP)
CIK:        0001699382
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164011
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PMV Pharma shareholders elect directors, approve say-on-pay, and ratify auditor
-------------------------------------------------------------------------------

- Re-elected Class III directors Richard Heyman (28.7M for), David Mack (35.2M for), and Laurie Stelzer (34.1M for).
- Non-binding advisory vote on executive compensation approved with 34.5M for, 0.8M against.
- Ratified Ernst & Young as independent auditor for FY2023 with 39.9M for, 2,087 against.
- All proposals passed; annual meeting held virtually on June 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699382/000119312523164011/0001193125-23-164011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699382/000119312523164011/d479825d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer